Manhattan Associates (MANH) EBITDA (2010 - 2026)

Manhattan Associates has disclosed EBITDA across 17 years of filings, most recently posting $66.2 million for Q2 2026.

• In Q2 2026, EBITDA fell 10.24% year-over-year to $66.2 million; the TTM figure through Jun 2026 stood at $274.0 million (changed 0.47% YoY), while the FY2025 annual figure was $279.8 million, up 6.96% from the prior year.
• EBITDA came in at $66.2 million for Q2 2026 at Manhattan Associates, up from $64.9 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $75.8 million in Q3 2025 to a low of $34.0 million in Q1 2022.
• Average EBITDA over 5 years is $57.5 million, with a median of $59.8 million recorded in 2023.
• The largest YoY upside for EBITDA was 64.7% in 2022 against a maximum downside of 13.29% in 2022.
• Over 5 years, EBITDA stood at $44.7 million in 2022, then surged by 31.67% to $58.9 million in 2023, then gained by 3.1% to $60.7 million in 2024, then climbed by 10.42% to $67.0 million in 2025, then retreated by 1.17% to $66.2 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $66.2 million in Q2 2026, $64.9 million in Q1 2026, and $67.0 million in Q4 2025.